Ara
Toplam kayıt 17, listelenen: 11-17
Recurrent candidal intertrigo: challenges and solutions
(Dove Medical Press Ltd, 2018)
Intertrigo is a common inflammatory dermatosis of opposing skin surfaces that can be caused by a variety of infectious agents, most notably candida, under the effect of mechanical and environmental factors. Symptoms such ...
Formation of functional nanobiocatalysts with a novel and encouraging immobilization approach and their versatile bioanalytical applications
(Royal Soc Chemistry, 2018)
The discovery of functional organic-inorganic hybrid nanoflowers (FNFs) consisting of proteins/enzymes as the organic components and Cu(ii) ion as the inorganic component has made an enormous impact on enzyme immobilization ...
Acne vulgaris and oxidation stress: Review
(2011)
Acne vulgaris is a common, chronic inflammatory disease of the pilosebaceous units. The pathogenesis of acne is not yet fully understood but thought to involve four key factors: ductal hyperkeratinization, sebogenesis, ...
Akut iskemik inmede son yaklaşımlar
(Turkish Society of Cerebrovascular Diseases, 2011)
Recent technological developments caused new methods of techniques in the treatment of brain ischemia. These methods could be categorized into two types as acute stage interventions and preventive techniques for development ...
Spinal surgery and neurosurgeon: Quo vadis?
(2013)
The aim of this review was to point out some critical points in spinal surgery. We present a good idea dealing with the subspecialisation in neurosurgery. Spine surgery is a good and especially timely example for it. The ...
Molecular targeted therapy in epithelial ovarian cancer
(Van Yuzuncu Yıl University, 2013)
Ovarian cancer is the most common cause of mortality of tumors from gynecologic origin and is often diagnosed after patients have already progressed to advanced disease stage. The current standard of care for treatment of ...
The potential for chemotherapy-free strategies in advanced prostate cancer
(S. Karger AG, 2019)
The treatment landscape for advanced prostate cancer is evolving rapidly, with new agents and strategies, and more optimal use of existing therapies under constant development. Efforts were focused on better understanding ...